Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma

被引:14
作者
Morgan, RJ
Newcomb, PV
Bailey, M
Hardwick, RH
Alderson, D
机构
[1] Univ Bristol, Bristol Royal Infirm, Dept Surg, Bristol BS2 8HW, Avon, England
[2] Univ Bristol, Div Mol & Cellular Biol, Bristol BS18 7DU, Avon, England
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1998年 / 24卷 / 01期
关键词
p53; p16; Rb; oesophageal adenocarcinoma;
D O I
10.1016/S0748-7983(98)80122-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims. Loss of cell cycle control is an important step in the development of human tumours. A number of tumour suppressor genes are involved in cell cycle control, including p16, p53 and Rb. The aim of this study was to seek evidence of deletions of these genes in oesophageal adenocarcinoma. Methods. Paired (tumour and normal squamous epithelium) frozen tissue samples from 12 patients were analysed by polymerase chain reaction (PCR) for loss of heterozygosity (LoH) at five microsatellite marker sites (two each for p16 and Rb, one for p53). Aneuploid tumour cell populations were sorted by flow cytometry prier to PCR, to eliminate stromal cell contamination. Results. Of the 12 tumours, 11 (92%) had LoH at one or more loci. LoH at the p53 locus occurred in nine of 12 tumours, at one or both p16 loci in seven of 11 tumours, and at one or both Rb loci in eight of 12 tumours. Five tumours had LoH at two tumour suppressor gene loci, and a further four tumours had LoH at loci for all three genes. Conclusions. Allelic deletions of p53, p16 and Rb are common in oesophageal adenocarcinoma, and may be important in the development of this disease.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 33 条
  • [1] CHRONIC PEPTIC ULCER OF THE OESOPHAGUS AND OESOPHAGITIS
    BARRETT, NR
    [J]. BRITISH JOURNAL OF SURGERY, 1950, 38 (150) : 175 - 182
  • [2] BLOUNT PL, 1991, CANCER RES, V51, P5482
  • [3] BOYNTON RF, 1991, CANCER RES, V51, P5766
  • [4] BRENTNALL TA, 1995, AM J PATHOL, V147, P561
  • [5] MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER
    BRONNER, CE
    BAKER, SM
    MORRISON, PT
    WARREN, G
    SMITH, LG
    LESCOE, MK
    KANE, M
    EARABINO, C
    LIPFORD, J
    LINDBLOM, A
    TANNERGARD, P
    BOLLAG, RJ
    GODWIN, AR
    WARD, DC
    NORDENSKJOLD, M
    FISHEL, R
    KOLODNER, R
    LISKAY, RM
    [J]. NATURE, 1994, 368 (6468) : 258 - 261
  • [6] ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION AND BARRETTS-ESOPHAGUS
    CAMERON, AJ
    LOMBOY, CT
    PERA, M
    CARPENTER, HA
    [J]. GASTROENTEROLOGY, 1995, 109 (05) : 1541 - 1546
  • [7] PHOSPHORYLATION OF THE RETINOBLASTOMA GENE-PRODUCT IS MODULATED DURING THE CELL-CYCLE AND CELLULAR-DIFFERENTIATION
    CHEN, PL
    SCULLY, P
    SHEW, JY
    WANG, JYJ
    LEE, WH
    [J]. CELL, 1989, 58 (06) : 1193 - 1198
  • [8] DEKA R, 1995, AM J HUM GENET, V56, P46174
  • [9] THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER
    FISHEL, R
    LESCOE, MK
    RAO, MRS
    COPELAND, NG
    JENKINS, NA
    GARBER, J
    KANE, M
    KOLODNER, R
    [J]. CELL, 1993, 75 (05) : 1027 - 1038
  • [10] Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma
    Gonzalez, MV
    Artimez, ML
    Rodrigo, L
    LopezLarrea, C
    Menendez, MJ
    Alvarez, V
    Perez, R
    Fresno, MF
    Perez, MJ
    Sampedro, A
    Coto, E
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (03) : 212 - 217